Romania's capital, Bucharest, faces gridlock and growing unrest as massive protests by farmers and truck drivers over soaring business costs and foreign competition bring the city to a standstill.
A potential second Trump presidency could trigger massive price hikes for life-changing diabetes and obesity medications due to proposed import tariffs, putting essential treatments at risk for millions of Britons.
Health Secretary Wes Streeting confronts major pharmaceutical firms, demanding transparency and fair pricing in the NHS's voluntary rebate scheme, which recouped £1.4bn last year.
An explosive investigation reveals how pharmaceutical giant Novartis leveraged a WHO-led initiative to push its expensive cancer drug in Nigeria and Kenya, raising serious ethical concerns about Big Pharma's role in public health.
The cost of diabetes and weight-loss drugs Mounjaro and Ozempic has surged, sparking concerns over affordability and market competition. Experts weigh in on the implications.
Popular diabetes and weight-loss drugs Ozempic and Mounjaro face price hikes as Trump-era tariffs on Chinese imports take effect. Experts warn of potential shortages and financial strain on patients.
Pharmaceutical giant Eli Lilly announces a significant price increase for its diabetes and weight-loss drug Mounjaro in the UK, sparking concerns over affordability and access.
Former Florida Attorney General Pam Bondi faces ethics complaints for allegedly lobbying the Justice Department on behalf of a pharmaceutical company while serving on a federal drug enforcement board.
A pharmaceutical executive faces charges after a horrific wrong-way collision claimed the life of a former Olympic swimmer. The shocking incident has sent shockwaves through the community.
The UK government has announced sweeping cuts to import tariffs on goods ranging from car parts to cucumbers in a move set to benefit businesses and consumers.
The pharmaceutical giant behind Mounjaro unveils an ambitious initiative to combat obesity in the UK, offering hope for millions struggling with weight-related health issues.
Ministers are under fire for approving a deal allowing Egypt to export food products to the UK amid concerns over food safety and domestic farming impacts.
US Republican Ralph Norman advocates for aggressive tariffs on Chinese imports, criticising Biden’s economic strategy and aligning with Trump’s trade policies.
Pharmaceutical giant Eli Lilly is developing an oral weight loss drug that may compete with injectable treatments like Wegovy. Early trials show promising results, potentially offering a more convenient alternative for patients.
Former President Donald Trump's proposed tariffs on imported vehicles may lead to higher car insurance premiums, experts warn, as costs for repairs and replacements surge.
Former US President Donald Trump has warned India of imposing steep tariffs on imports if re-elected, escalating trade tensions between the two nations.
Delhi authorities have busted a massive counterfeit drug operation, with fake versions of Johnson & Johnson and GSK products seized. The racket poses serious health risks to consumers.
Former US President Donald Trump proposes imposing 50% tariffs on Indian goods if re-elected, citing India's reliance on Russian oil as a national security threat.
Former US President Donald Trump has suggested imposing 50% tariffs on Indian goods in response to India's continued oil imports from Russia. This bold move could escalate trade tensions and reshape global economic alliances.
The US Food and Drug Administration (FDA) has approved a new Alzheimer's treatment, sparking debate over its efficacy and high cost while offering hope to millions.
Shares in major European pharmaceutical firms plummet as investors react to potential US tariffs, sparking market volatility and sector-wide uncertainty.
Sales of Novo Nordisk's blockbuster diabetes medications, including Ozempic, have dropped unexpectedly. Experts weigh in on the causes and future implications.
Former US President Donald Trump has floated the idea of imposing tariffs on imported pharmaceuticals, a move that could significantly impact the UK's healthcare sector and drug prices.
Former President Donald Trump’s controversial proposal to slash drug prices has reignited tensions with pharmaceutical giants. Critics warn of risks to innovation, while advocates hail it as a win for patients.
Former US President Donald Trump proposes sweeping tariffs on imports, sparking debate over economic impacts and potential trade wars. Experts weigh in on the consequences for the UK and global markets.
India has ramped up imports of discounted Russian crude oil despite US warnings of potential sanctions, as New Delhi seeks to secure affordable energy supplies amid global market volatility.
Ford Motor Company is leveraging a controversial tariff exemption from the Trump administration to cut production costs on vehicles imported from China, sparking debate over trade fairness.
Labour leader Keir Starmer vows to confront pharmaceutical giants over soaring drug prices, promising relief for the NHS and patients. Will his strategy work?
Former US President Donald Trump calls on British pharmaceutical companies to reduce drug prices for the NHS, sparking debate on healthcare affordability.
The Biden administration is reportedly considering raising tariffs on Chinese imports, a move that could escalate trade tensions and impact global markets.